IONS
Ionis Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -5.9% ·
aandelenstroom +30.0% ·
netto nieuwe posities -6.2%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +2 | 148.59M | $11.08B | +6 | −3 |
| Q1 2026 | 139 | -2 | 142.62M | $9.86B | +6 | −9 |
| Q4 2025 | 142 | 0 | 143.10M | $10.36B | +1 | — |
| Q3 2025 | 25 | +4 | 95.56M | $6.25B | +5 | −2 |
| Q2 2025 | 19 | +1 | 95.25M | $3.76B | +1 | — |
| Q1 2025 | 15 | -1 | 43.90M | $1.32B | +1 | −2 |
| Q4 2024 | 16 | -1 | 43.25M | $1.51B | — | −1 |
| Q3 2024 | 16 | -1 | 34.86M | $1.40B | — | −1 |
| Q2 2024 | 17 | — | 24.68M | $1.18B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 8.74M | +33.0% | $349.96M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Capital World Investors ✦ | 7.83M | +247.6% | $313.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 4.21M | +7.0% | $168.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 4.21M | +7.0% | $168.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Tweedy, Browne ✦ | 3.45M | 0.0% | $138.39M | 6.6% | Held | 2 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passief) | 2.67M | +7.4% | $106.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passief) | 2.67M | +7.4% | $106.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Norges Bank ✦ (passief) | 2.03M | +98.9% | $81.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 1.92M | +1008.8% | $76.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | Marshall Wace ✦ | 1.92M | +1008.8% | $76.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 19 | ARK Investment Management ✦ | 1.38M | +1.7% | $55.45M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 919.08K | -10.6% | $36.82M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 500.00K | -37.5% | $20.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Millennium Management ✦ | 430.72K | +235.9% | $17.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 401.15K | -36.0% | $16.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 401.15K | -36.0% | $16.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 190.51K | -23.6% | $7.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 145.09K | -23.9% | $5.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 145.09K | -23.9% | $5.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | Baillie Gifford ✦ | 39.58K | -84.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | Baillie Gifford ✦ | 39.58K | -84.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | Baillie Gifford ✦ | 39.58K | -84.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Gotham Asset Management ✦ | 6.26K | 0.0% | $250,856 | 0.0% | Held | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Point72 Asset Management | $6.54M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 490 houders, 170.17M aandelen, $11.94B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.